The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Randomized Trial of Plasma Exchange or High-Dosage Methylprednisolone as Adjunctive Therapy for Severe Renal Vasculitis
Abstract
Systemic vasculitis associated with autoantibodies to neutrophil cytoplasmic antigens (ANCA) is the most frequent cause of rapidly progressive glomerulonephritis. Renal failure at presentation carries an increased risk for ESRD and death despite immunosuppressive therapy. This study investigated whether the addition of plasma exchange was more effective than intravenous methylprednisolone in the achievement of renal recovery in those who presented with a serum creatinine >500 micromol/L (5.8 mg/dl). A total of 137 patients with a new diagnosis of ANCA-associated systemic vasculitis confirmed by renal biopsy and serum creatinine >500 micromol/L (5.8 mg/dl) were randomly assigned to receive seven plasma exchanges (n = 70) or 3000 mg of intravenous methylprednisolone (n = 67). Both groups received oral cyclophosphamide and oral prednisolone. The primary end point was dialysis independence at 3 mo. Secondary end points included renal and patient survival at 1 yr and severe adverse event rates. At 3 mo, 33 (49%) of 67 after intravenous methylprednisolone compared with 48 (69%) or 70 after plasma exchange were alive and independent of dialysis (95% confidence interval for the difference 18 to 35%; P = 0.02). As compared with intravenous methylprednisolone, plasma exchange was associated with a reduction in risk for progression to ESRD of 24% (95% confidence interval 6.1 to 41%), from 43 to 19%, at 12 mo. Patient survival and severe adverse event rates at 1 yr were 51 (76%) of 67 and 32 of 67 (48%) in the intravenous methylprednisolone group and 51 (73%) of 70 and 35 of (50%) 70 in the plasma exchange group, respectively. Plasma exchange increased the rate of renal recovery in ANCA-associated systemic vasculitis that presented with renal failure when compared with intravenous methylprednisolone. Patient survival and severe adverse event rates were similar in both groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · PubMed · Cited by 33,716
Nomenclature of Systemic Vasculitides
Jennette, J. C., Falk, R. J., Andrassy, K., Bacon, P. A., Churg, J., Gross, W. L., Hagen, E. C., Hoffman, G. S., Hunder, G. G., Kallenberg, C. G. M., et al. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370206 · Cited by 3,845
Self-citationJayne, D., Rasmussen, N., Andrassy, K., Bacon, P., Tervaert, J. W. C., Dadoniené, J., Ekstrand, A., Gaskin, G., Gregorini, G., de Groot, K., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020286 · Cited by 1,348
Self-citationFalk, R. J., Terrell, R. S., Charles, L. A., & Jennette, J. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4115 · Cited by 1,261
Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.
Luqmani, R. A., BACON, P. A., Moots, R. J., Janssen, B. A., Pall, A. A., Emery, P., Savage, C. O. S., & Adu, D. (1994) · PubMed · Cited by 1,056
Self-citationXiao, H., Heeringa, P., Hu, P., Liu, Z., Zhao, M., Aratani, Y., Maeda, N., Falk, R. J., & Jennette, J. C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15918 · Cited by 1,005
De Groot, K., Rasmussen, N., Bacon, P. A., Tervaert, J. W. C., Feighery, C., Gregorini, G., Gross, W. L., Luqmani, R., & Jayne, D. R. W. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21142 · Cited by 801
Self-citationHagen, E. C., Daha, M. R., Hermans, J., Andrassy, K., Csernok, E., Gaskin, G., Lesavre, P., Lüdemann, J., Rasmussen, N., Sinico, R. A., et al. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00807.x · Cited by 740
Self-citationLevy, J. B., Turner, A. N., Rees, A. J., & Pusey, C. D. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-11-200106050-00009 · Cited by 623
Self-citationExley, A. R., Bacon, P. A., Luqmani, R. A., Kitas, G. D., Gordon, C., Savage, C. O. S., & Adu, D. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400222 · Cited by 619
Self-citationOutcome of ANCA-associated renal vasculitis: a 5-year retrospective study
Booth, A. D., Almond, M. K., Burns, A., Ellis, P., Gaskin, G., Neild, G. H., Plaisance, M., Pusey, C. D., & Jayne, D. R. W. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00025-8 · Cited by 504
Self-citationIMMUNOSUPPRESSION AND PLASMA-EXCHANGE IN THE TREATMENT OF GOODPASTURE'S SYNDROME
Lockwood, C. M., Pearson, T. A., Rees, A. J., Evans, D. J., Peters, D. K., & Wilson, C. B. (1976) · The Lancet · doi:10.1016/s0140-6736(76)93089-0 · Cited by 440
Boomsma, M. M., Stegeman, C. A., Van Der Leij, M. J., Oost, W., Hermans, J., Kallenberg, C. G. M., Limburg, P. C., & Tervaert, J. W. C. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200009)43:9<2025::aid-anr13>3.0.co;2-o · Cited by 434
Self-citationPlasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies
Pusey, C. D., Rees, A. J., Evans, D. J., Peters, D. K., & Lockwood, C. M. (1991) · Kidney International · doi:10.1038/ki.1991.272 · Cited by 358
Self-citationWestman, K. W., Bygren, P. G., Olsson, H., Ranstam, J., & Wieslander, J. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v95842 · Cited by 318
Self-citationHauer, H. A., Bajema, I. M., Van Houwelingen, H. C., Ferrario, F., Noël, L.-H., Waldherr, R., Jayne, D. R. W., Rasmussen, N., Bruijn, J. A., & Hagen, E. C. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00089.x · Cited by 317
Self-citationLittle, M. A., Smyth, C. L., Yadav, R., Ambrose, L., Cook, H. T., Nourshargh, S., & Pusey, C. D. (2005) · Blood · doi:10.1182/blood-2005-03-0921 · Cited by 276
Self-citationde Lind van Wijngaarden, R. A. F., Hauer, H. A., Wolterbeek, R., Jayne, D. R. W., Gaskin, G., Rasmussen, N., Noe[Combining Diaeresis]l, L.-H. A. A. G. A., Ferrario, F., Waldherr, R. D., Hagen, E. C., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005080870 · Cited by 258
Self-citationGuillevin, L., Lhote, F., Cohen, P., Jarrousse, B., Lortholary, O., Généreau, T., Léon, A., & Bussel, A. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780381116 · Cited by 229
Self-citationPulmonary renal syndrome: A 4-year, single-center experience
Gallagher, H., Kwan, J. T. C., & Jayne, D. R. W. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.29876 · Cited by 209
Self-citationAntimyeloperoxidase-associated proliferative glomerulonephritis: an animal model.
Brouwer, E., Huitema, M. G., Klok, P. A., de Weerd, H., Tervaert, J. W., Weening, J. J., & Kallenberg, C. G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.905 · Cited by 203
Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency
Haubitz, M., Bohnenstengel, F., Brunkhorst, R., Schwab, M., Hofmann, U., & Busse, D. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00279.x · Cited by 177
Jayne, D. R., & Rasmussen, N. (1997) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)63594-5 · Cited by 169
Self-citationMethylprednisolone Therapy for Acute Crescentic Rapidly Progressive Glomerulonephritis
Bolton, K., & Sturgill, B. C. (2008) · American Journal of Nephrology · doi:10.1159/000167998 · Cited by 107
Frasca, G. M., Soverini, M. L., Falaschini, A., et al. (2003) · Therapeutic Apheresis and Dialysis · doi:10.1046/j.1526-0968.2003.00089.x · Cited by 52
Cited by
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Rovin, B. H., Adler, S. G., Barratt, J., Bridoux, F., Burdge, K. A., Chan, T. M., Cook, H. T., Fervenza, F. C., Gibson, K. L., Glassock, R. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.05.021 · Cited by 2,518
Self-citationPadmanabhan, A., Connelly‐Smith, L., Aqui, N., Balogun, R. A., Klingel, R., Meyer, E., Pham, H. P., Schneiderman, J., Witt, V., Wu, Y., et al. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21705 · Cited by 2,230
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
Jones, R. B., Cohen Tervaert, J. W., Hauser, T., Luqmani, R., Morgan, M. D., Peh, C. A., Savage, C. O., Segelmark, M., Tesar, V., van Paassen, P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909169 · Cited by 1,748
Self-citationModification and validation of the Birmingham Vasculitis Activity Score (version 3)
Mukhtyar, C., Lee, R., Brown, D., Carruthers, D., Dasgupta, B., Dubey, S., Flossmann, O., Hall, C., Hollywood, J., Jayne, D., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.101279 · Cited by 1,224
Self-citationEULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
Yates, M., Watts, R. A., Bajema, I. M., Cid, M. C., Crestani, B., Hauser, T., Hellmich, B., Holle, J. U., Laudien, M., Little, M. A., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209133 · Cited by 1,194
Self-citation
Metadata
- Authors
- Jayne, D. R. W., Gaskin, G., Rasmussen, N., Abramowicz, D., Ferrario, F., Guillevin, L., Mirapeix, E., Savage, C. O. S., Sinico, R. A., Stegeman, C. A., Westman, K. W., van der Woude, F. J., de Lind van Wijngaarden, R. A. F., & Pusey, C. D.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2007-07
- Volume
- 18
- Issue
- 7
- Pages
- 2180-2188
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2151319492
- Cited by
- 1,125
- References
- 25
- FWCI
- 47.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.